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259JACC Vol. 55, No. 3, 2010 Correspondence
January 19, 2010:255–69ultiple Bioelectric
mpedance Vectors
n the Monitoring of
ongestive Heart Failure
was delighted to read the report by Khoury et al. (1) in the March
4, 2009, issue of the Journal, related to an area I have been
nterested in since 1998, namely, using electrocardiography in
onitoring the edematous state of patients with varying pathologic
eatures, including congestive heart failure (CHF) (2). The authors
valuated the response of 6 bioelectric impedance signals in 15
ogs with CHF due to cardiomyopathy imparted by chronic rapid
ight ventricular pacing by using a variety of electrode configura-
ions of a cardiac resynchronization system that they had im-
lanted. The key finding of this study is that the left ventricular
ing-to-can vector represented the electrode configuration with the
astest and largest change in impedance and had the best correla-
ion with the rise in the left ventricular end-diastolic dimension
nd left atrial pressure noted with the worsening of CHF. The
linical implications here are that a left ventricular lead, in contrast
o a right ventricular lead currently used, has advantages in the
mbulatory monitoring of CHF. Particularly worrisome is the
reviously described moderate rate of false positive results of
ecreasing impedance, measured via the right ventricular lead, in
atients who did not have hemodynamic deterioration leading to
ung congestion. What I do not understand is why, despite this,
he authors urge the use of measurements and monitoring of
mpedance through multiple electrode configurations, instead of
nly using the left ring-to-can electrode, which they found themselves
o be superior to any of the other 5 electrode configurations. What
s the objective of such a recommendation? Do they imply that
heir results need confirmation by other animal investigations, or
hat their findings require corroboration in human studies, or that
hey still suspect that the other 5 electrode configurations may have
ome special role to play? And if the latter is the case, what role?
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e thank Dr. Madias both for his support of the study findings (1)
nd for his endorsement of the clinical relevance. Reliable moni-
oring of heart failure depends on both the sensor technology and
he detection algorithm. The study focused on the former subject,
amely, measuring impedance via lead sensors readily available in
mplanted cardiac resynchronization therapy systems. Although
mpedance measured in between the left ventricular (LV) lead and
he Can yielded the largest and fastest change during heart failure
n comparison with only right-side heart electrodes, other imped-
nce vectors using the LV lead also were associated with variable
ut favorable trends. The study was not designed to determine an
ptimal detection algorithm on the basis of impedance measure-
ents in part because of limitations of the animal model itself.
herefore, it is premature to conclude with certainty that one lead
onfiguration (i.e., LV-Can) is superior to 1 or more combinations
f impedance vectors for monitoring heart failure in patients.
linical trials will be necessary to address this issue. Several factors
ould impact trends in impedance measured via different electrode
onfigurations that include: 1) heart and torso anatomy and mass;
) lead electrode location; 3) type and cause of heart failure; 4)
oncomitant pharmacologic therapy; 5) pulmonary disease; 6)
ubcutaneous edema; and 7) skeletal muscle resistivity. Given its
cope, the study did not advocate using multiple impedance vectors
ver a single LV-Can configuration, but rather, speculated on
ossible benefits of using more than 1 vector for sensing, especially
hen considering the above foreseeable confounding factors in
eal-life scenarios. This could be particularly attractive when no
dditional hardware is required and when the platform circuitry of
he implanted system affords monitoring multiple impedance
arameters.
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